TP53 and cancer: Intriguingly, exosomes released from mutant p53-expressing cancer cells enhance integrin trafficking in fibroblasts via the Rab-coupling protein (RCP)/diacylglycerol kinase-α (DGKα) pathway, leading to pro-invasive ECM remodeling that could serve as pre-metastatic niches in target organs [78].